REFRACTORY DESMOID FIBROMATOSIS

Clinical trials for REFRACTORY DESMOID FIBROMATOSIS explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY DESMOID FIBROMATOSIS trials appear

Sign up with your email to follow new studies for REFRACTORY DESMOID FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for kids with tough cancers: experimental drug trial opens

Disease control Recruiting now

This study is testing a new drug called tegavivint in children and young adults whose solid tumors have come back or have not responded to other treatments. The main goals are to find the safest dose, understand the side effects, and see if the drug can help shrink tumors. Tegavi…

Matched conditions: REFRACTORY DESMOID FIBROMATOSIS

Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

REFRACTORY DESMOID FIBROMATOSIS

Get alerted when new REFRACTORY DESMOID FIBROMATOSIS trials appear

New hope for kids with tough cancers: experimental drug trial opens